Table of Contents
The Rational Basis for FRANDly Courts Denying Injunctive Relief for SEPs Infringement |
|
| Pai, Yogesh | 146-156 |
Articles
| Landmark Pharma Patent Jurisprudence in India | |
| Nair, Gopakumar G | 79-88 |
| The Weakening of Pharmaceutical Method Patents: The Federal Circuit Addresses the ‘FDA Conundrum’ | |
| Higgins, Brian Wm.; Lessler, Jay P. | 89-96 |
| Oppositions against European patents: Three successful examples of oppositions lodged by Indian opponents | |
| Köster, Christian | 97-103 |
| Access to Medicines in Developing Countries and Free Trade Agreements: the Case of the US-DR-CAFTA with Focus on Costa Rica. | |
| Pusceddu, Piergiuseppe | 104-112 |
| On the Challenges Facing Patent Pooling inBiotechnology | |
| Jeitschko, Thomas D. | 113-122 |
| Reflections on recent developments of statutory public interests in patent-based Section 337 proceedings | |
| Yu, Yang | 123-132 |
Ghostwriting in Polish Copyright Law – a new perspective needed?
|
|
| Jankowska, Marlena Maria | 133-140 |
column
| The Court of Justice Recasts the EU Patent Term Extension System | |
| Cook, Trevor | 141-145 |
Journal of Intellectual Property Rights (JIPR)